Literature DB >> 32642860

The Management of rNPC: Salvage Surgery vs. Re-irradiation.

Chung-Yu Hao1, Sheng-Po Hao2,3.   

Abstract

PURPOSE OF REVIEW: Treatment failure, in the form of either persistence or local recurrence, occurs in 10 to 30% of nasopharyngeal carcinoma patients after initial radiotherapy (RT). Early detection of persistent or recurrent disease aids in the recognition of tumors that can be candidates for salvage nasophayngectomy or re-irradiation. There is no consensus till now on the indications or selection of the above two salvage treatment. RECENT
FINDINGS: In recent years, there has been a paradigm shift from open to endoscopic approach for nasopharyngectomy, which carries nearly no complications. For salvage re-irradiation, intensity-modulated radiotherapy (IMRT) is the most commonly indicated modality. Compared to IMRT, salvage endoscopic nasopharyngectomy may be more beneficial in terms of prolonging survival, improving quality of life, and minimizing treatment-related complications and medical costs in a selected subset of recurrent nasopharyngeal carcinoma (rNPC) patients. Salvage nasopharyngectomy should be the mainstay of treatment for rNPC.

Entities:  

Keywords:  IMRT; Re-irradiation; Salvage nasopharyngectomy; Salvage therapy; rNPC

Year:  2020        PMID: 32642860     DOI: 10.1007/s11912-020-00949-0

Source DB:  PubMed          Journal:  Curr Oncol Rep        ISSN: 1523-3790            Impact factor:   5.075


  6 in total

Review 1.  Recurrent Nasopharyngeal Cancer: Critical Review of Local Treatment Options Including Recommendations during the COVID-19 Pandemic.

Authors:  Michaela Svajdova; Marian Sicak; Pavol Dubinsky; Marek Slavik; Pavel Slampa; Tomas Kazda
Journal:  Cancers (Basel)       Date:  2020-11-25       Impact factor: 6.639

2.  Comparing the Effectiveness of Endoscopic Surgeries With Intensity-Modulated Radiotherapy for Recurrent rT3 and rT4 Nasopharyngeal Carcinoma: A Meta-Analysis.

Authors:  Zhouying Peng; Yumin Wang; Yaxuan Wang; Ruohao Fan; Kelei Gao; Hua Zhang; Weihong Jiang
Journal:  Front Oncol       Date:  2021-07-26       Impact factor: 6.244

3.  Comparison of radiotherapy combined with nimotuzumab vs. chemoradiotherapy for locally recurrent nasopharyngeal carcinoma.

Authors:  Jing-Feng Zong; Qian-Dong Liang; Qiong-Jiao Lu; Yu-Hong Liu; Han-Chuan Xu; Bi-Juan Chen; Qiao-Juan Guo; Yun Xu; Cai-Rong Hu; Jian-Ji Pan; Shao-Jun Lin
Journal:  BMC Cancer       Date:  2021-11-25       Impact factor: 4.430

4.  SEOM-TTCC clinical guideline in nasopharynx cancer (2021).

Authors:  Antonio Rueda Domínguez; Beatriz Cirauqui; Almudena García Castaño; Ruth Alvarez Cabellos; Alberto Carral Maseda; Beatriz Castelo Fernández; Leticia Iglesias Rey; Jordi Rubió-Casadevall; Virginia Arrazubi; Ricard Mesía
Journal:  Clin Transl Oncol       Date:  2022-03-18       Impact factor: 3.405

Review 5.  Treatment of Recurrent Nasopharyngeal Carcinoma: A Sequential Challenge.

Authors:  Zhouying Peng; Yumin Wang; Ruohao Fan; Kelei Gao; Shumin Xie; Fengjun Wang; Junyi Zhang; Hua Zhang; Yuxiang He; Zhihai Xie; Weihong Jiang
Journal:  Cancers (Basel)       Date:  2022-08-25       Impact factor: 6.575

6.  Clinical Outcomes of Salvage Endoscopic Nasopharyngectomy for Patients With Advanced Recurrent Nasopharyngeal Carcinoma.

Authors:  Wanpeng Li; Huankang Zhang; Hanyu Lu; Huan Wang; Yurong Gu; Houyong Li; Xicai Sun; Hongmeng Yu; Dehui Wang
Journal:  Front Oncol       Date:  2021-07-22       Impact factor: 6.244

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.